Last reviewed · How we verify
NCT06792227: F-EET
Family-Based Treatment at Home in Adolescents With Eating Disorders and Co-occurring Mental Health Conditions
NA trial testing FBT-H in Eating Disorders in 10 participants. Enrolling by invitation.
1 April 2026
Quick facts
| Lead sponsor | Karakter Kinder- en Jeugdpsychiatrie |
|---|---|
| Phase | NA |
| Status | ENROLLING BY INVITATION |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | sequential |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 10 |
| Start date | 1 November 2023 |
| Primary completion | 1 April 2026 |
| Estimated completion | 1 April 2026 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- FBT-H
Conditions studied
- Eating Disorders — all drugs for Eating Disorders →
- Anorexia Nervosa — all drugs for Anorexia Nervosa →
- Eating Disorder Not Otherwise Specified — all drugs for Eating Disorder Not Otherwise Specified →
Sponsor
Karakter Kinder- en Jeugdpsychiatrie
Who can join
Adults 12 to 18, any sex, with Eating Disorders or Anorexia Nervosa. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The significant impact of eating disorders on adolescents necessitates the evaluation of current treatments. Family-based Treatment (FBT) is the standard treatment but has modest remission rates, highlighting the need for improvements. Assessing its effectiveness in adolescents with co-occurring mental health conditions is also crucial. In the Netherlands, there is a growing focus on home-based treatment. This study aims to enhance remission rates in FBT by adapting it for use in a home setting (FBT-H).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Family-based treatment at home in adolescents with eating disorders and co-occurring mental health conditions: rationale and study design of a mixed methods trial.
Schapink AH, van der Velde J, Winkelhorst K, Kaijadoe S, et al · · 2025 · cited 1× · PMID 40200161 · DOI 10.1186/s12888-025-06672-z
Verify or expand the search:
- PubMed search for NCT06792227
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Eating Disorders
Currently open trials in the same condition.
- NCT07237607 — Developing an Artificial Intelligence (AI) Chatbot for Adolescents and Young Adults With Eating Disorders · NA · recruiting
- NCT07295197 — Oral Indicators for ED Screening · recruiting
- NCT07082777 — Recovery in Telling Life Stories · NA · recruiting
- NCT07042672 — Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity · recruiting
- NCT07017322 — Non-invasive Cranial Electrical Stimulation for Mealtime Anxiety in Adults With Eating Disorders · NA · recruiting
Other Karakter Kinder- en Jeugdpsychiatrie trials
Trials by the same sponsor.
- NCT05987735 — Psycho-education Program BLAME-LESS and It's Effect on Traumarelated Shame and Guilt · NA · enrolling by invitation
- NCT05547334 — IBA Treatment in Adolescents With OCD · NA · unknown
- NCT03220308 — Mindfulness Training for Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and Mindful Parenting · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06792227 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Karakter Kinder- en Jeugdpsychiatrie
- Last refreshed: 24 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06792227.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing